EXO Biologics S.A.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm Infants (NCT06279741) | EXO Biologics S.A. | 2023-12-28 |
Track EXO Biologics S.A. automatically
Every clearance here is in the API, with alerts when new ones post.